Total Funding
30
55
Total FundingGrant raised
Growth Score
0 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
169184
Vivasc Therapeutics is a drug development company that specializes in proprietary cardiac targeting peptide platform technology.
- Chip Dougherty: President and CEOPast Role: Vorys, Sater, Seymour and Pease LLP, Counsel
About the Company
Vivasc Therapeutics is a drug development company. They offer services that include drug development, cardiology, atrial fibrillation, and AFiB.
